JOINT FILING AGREEMENTJoint Filing Agreement • July 6th, 2018 • Aklog Lishan • Surgical & medical instruments & apparatus
Each Party hereto represents to the other Party that it is eligible to use Schedule 13D to report its beneficial interest in shares of common stock, $.001 par value per share, of PAVmed Inc. (as amended or supplemented, the “Schedule 13D”).
